Search results
Morning exercise may be optimal for improving bone health
New Scientist· 23 hours agoMice that exercised soon after waking up had stronger and longer bones than those that exercised...
Gen Z’s love for vaping could be the reason they’re ‘aging like milk’: docs
NY Post via Yahoo News· 2 days ago“Nicotine is the active ingredient, and it is associated with all kinds of skin problems. It is...
10 Science-Backed Benefits of Turmeric for Skin
Prevention· 6 days agoThe complete list of the root’s pros is too long to cover here, but we can dive into the benefits of turmeric for skin. Meet the Experts: Daniel...
Extreme Temperatures Tied to Elevated Stroke Mortality Risk
Medscape· 12 hours agoExtreme temperatures are linked to an increased stroke mortality risk, especially for those in...
New Form of Male Birth Control 100% Effective in Mice
Medscape· 12 hours agoA new candidate has emerged in the quest for a male birth control pill. Researchers at Baylor...
10 Science-Backed Benefits of Turmeric for Skin
Prevention via Yahoo News· 6 days agoIn a separate study, blue light and curcumin were found to be an effective treatment of skin infections like MRSA in mice. It has been found to aid in ...
Why Mindy Kaling Is Advocating for a Health Condition She Doesn't Have
SheKnows· 7 days agoMindy Kaling is no stranger to advocating for herself. Before she created hit shows like The Mindy...
Tazarotene vs. Tretinoin: Comparing These Two Retinoids
Verywell Health via Yahoo News· 4 days agoTazarotene and tretinoin are retinoids that treat acne and reduce the effects of aging on skin....
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 1 day agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 10 hours agoUNION therapeutics announces successful completion of the ADESOS Phase 2b study and presentation of data at the RAVE Conference 2024 PR Newswire HELLERUP, Denmark, June 4, 2024 ADESOS Phase 2b study evaluating orismilast as an oral treatment in
